Marksans Pharma Limited has informed the Exchange regarding a press release dated November 10, 2025, titled " US FDA cGMP inspection at Company s 2nd manufacturing facility located at Plot No. A-1, Phase 1-A, Verna Industrial Estate, Verna, Goa, India concluded with zero Form 483 observation.".